Showing results (61-70 of 86) with videos related to
Sort By:
Pageof 9
Nature Immunology|December 27, 2016
Ubiquitination of hnRNPA1 by TRAF6 links chronic innate immune signaling with myelodysplasiaJing Fang, Lyndsey C Bolanos, Kwangmin Choi, et al.Cell Reports|December 24, 2014
p62 is required for stem cell/progenitor retention through inhibition of IKK/NF-κB/Ccl4 signaling at the bone marrow macrophage-osteoblast nicheKyung Hee Chang, Amitava Sengupta, Ramesh C Nayak, et al.Leukemia|July 16, 2025
Targeting of IRAK4 and GSPT1 enhances therapeutic efficacy in AML via c-Myc destabilizationEric J Vick, Aishlin Hassan, Kwangmin Choi, et al.Leukemia Research|October 5, 2016
Possible role of intragenic DNA hypermethylation in gene silencing of the tumor suppressor gene NR4A3 in acute myeloid leukemiaRyo Shimizu, Tomoya Muto, Kazumasa Aoyama, et al.The Journal of Clinical Investigation|March 10, 2020
Targeting AML-associated FLT3 mutations with a type I kinase inhibitorLaQuita M Jones, Katelyn Melgar, Lyndsey Bolanos, et al.Nature Cell Biology|April 24, 2019
U2AF1 mutations induce oncogenic IRAK4 isoforms and activate innate immune pathways in myeloid malignanciesMolly A Smith, Gaurav S Choudhary, Andrea Pellagatti, et al.Biorxiv : the Preprint Server for Biology|February 19, 2024
Broad de-regulated U2AF1 splicing is prognostic and augments leukemic transformation via protein arginine methyltransferase activationMeenakshi Venkatasubramanian, Leya Schwartz, Nandini Ramachandra, et al.Cell Chemical Biology|January 7, 2026
Scaffolding-dependent CASP1 constrains excessive cell-intrinsic inflammatory signaling in leukemiaEmma E Uible, Issac Choi, Courtnee A Clough, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2024
Smoking-Associated Carcinogen-Induced Inflammation Promotes Lung Carcinogenesis via IRAK4 ActivationRitesh K Aggarwal, Simone Sidoli, Jingli Wang, et al.Science Translational Medicine|May 7, 2025
Splicing regulatory dynamics for precision analysis and treatment of heterogeneous leukemiasMeenakshi Venkatasubramanian, Leya Schwartz, Nandini Ramachandra, et al.Pageof 9